http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0165226-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C301-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00 |
| filingDate | 1985-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4878d4b678b4292893a30b97a3f39d97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d70f6dad704780e11e66e1606433977 |
| publicationDate | 1985-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0165226-A2 |
| titleOfInvention | 4-Amino-butanoic-acid derivatives, preparation and use |
| abstract | M représente un atome de métal alcalin, R représente un groupement amino protégé, R, représente un groupement labile, R 2 représente hydrogène, un radical alkyle, linéaire ou ramifié, ayant de 1 à 6 atomes de carbone, un radical méthyloxyalkyle inférieur, un radical méthylthioalkyle inférieur, un radical (alkyle inférieur) aminoalkyle inférieur, un radical (dialkyle inférieur) aminoalkyle inférieur, un radical hydroxyalkyle inférieur ou R 2 représente l'un des radicaux de formules générales:n dans lesquelles: Cy représente un radical hydrocarboné aromatique ou alicycyc-lique ou un radical hétérocyclique contenant un atomed'oxygène ou de soufre ou un ou deux atomes d'azote, Cy étant éventuellement mono-, di- ou tri-substitué par desradicaux hydroxy, alkyle inférieur, alkoxy inférieur, trifluorométhyle, nitro ou halogéno, A représente une liaison simple ou un radical alkylène, linéaire ou ramifié, ayant de 1 à 5 atomes de carbone, A' représente un radical alkylène, linéaire ou ramifié, ayant de 1 à 5 atomes de carbone, R 3 représente un groupement S-protecteur. The invention relates to new 4-amino butanoic acid derivatives of general formula: in which: M represents an alkali metal atom, R represents a protected amino group, R represents a labile group, R 2 represents hydrogen, an alkyl radical, linear or branched, having from 1 to 6 carbon atoms, a lower methyloxyalkyl radical, a lower methylthioalkyl radical, a lower aminoalkyl (lower alkyl) radical, a lower aminoalkyl (lower dialkyl) radical, a lower hydroxyalkyl radical or R 2 represents one of the radicals of general formulas: in which: Cy represents an aromatic or alicycyclic hydrocarbon radical or a heterocyclic radical containing an oxygen or sulfur atom or one or two nitrogen atoms, Cy being optionally mono-, di- or tri-substituted by hydroxy, lower alkyl radicals, lower alkoxy, trifluoromethyl, nitro or halo, A represents a single bond or an alkylene radical, linear or branched, having from 1 to 5 carbon atoms, A 'represents an alkylene radical, linear or branched, having from 1 to 5 carbon atoms, R 3 represents an S-protective group. n n n These compounds are useful as intermediates, in particular for the final synthesis of (3S, 4S) -3-hydroxy-4-amino-6 methyl-6 heptanoic acid or statin. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0306143-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2590894-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225311-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225311-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4788322-A |
| priorityDate | 1984-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 268.